LAS VEGAS, Feb 26, 2010 Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today it has named Shamoon Ahmad, M.D., M.B.A., FACP as Medical Director and Leader of its Medical Advisory Board.

Technical outlook:  CBAI continues to hammer out a bottom in the .008 -009 range. Traders and investors are anxiously waiting to see if we can break above the 50 day moving average which seems to be a short-term roadblock. A weekly close above the psychological .01 area could provide the catalyst to break through the 50 day moving average in next weeks trading.

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.